2 ms·
I've suspected for a long time that Insulin resistance is going to be one of the next big areas of focus for public health, but I thought that it was going to h
by ashtonkem 6y ago
I've suspected for a long time that Insulin resistance is going to be one of the next big areas of focus for public health, but I thought that it was going to happen the moment Apple finally figured out blood glucose measurement through the skin. I did not see a pandemic being part of it.
- gumby 6y agoI love my Apple watch but I am astonished at your faith in their ability to do noninvasive glucose measurement. People have broken their picks on that particular coal face for decades. For that matter DM2 is an area of quite active research (and, like diagnosis, has been quite active for decades) as the financial payoff for any success is enormous. The only downside for transdermal diagnosis is the lack of consumables, which makes it a tough market to enter and to be funded for. That is an area that's good for Apple as they are already selling the platform, so this would be a feature that would add to sales. And one I'd use.
- dreamcompiler 6y agoO2sat measurement has been noninvasive without consumables for a long time and many phones can do it now. Why do consumables matter?
- gumby 6y agoInvestors don’t typically like diagnostics as the margins and volume tend to be quite low. They also tend to be more “vitamin” than “aspirin”.* Consumables, a least, give you recurring revenue and even in some cases the opportunity for a razor-and-blades model. You’d be surprised how many med products are designed specifically to require consumables. * (funny analogy to use in a med context)